Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 132.40
Day range
SAR 130.80 - SAR 133.20
Year range
SAR 107.00 - SAR 156.00
Market cap
2.64B SAR
Avg Volume
44.92K
P/E ratio
33.11
Dividend yield
1.51%
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 135.99M | 5.28% |
Operating expense | 38.88M | 11.32% |
Net income | 44.81M | -1.31% |
Net profit margin | 32.95 | -6.26% |
Earnings per share | — | — |
EBITDA | 49.52M | -2.50% |
Effective tax rate | 3.50% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.65M | 49.90% |
Total assets | 526.78M | 16.35% |
Total liabilities | 158.57M | 8.35% |
Total equity | 368.21M | — |
Shares outstanding | 20.00M | — |
Price to book | 7.19 | — |
Return on assets | 22.85% | — |
Return on capital | 27.98% | — |
Cash Flow
Net change in cash
| (SAR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 44.81M | -1.31% |
Cash from operations | 22.78M | -53.53% |
Cash from investing | -4.88M | 65.18% |
Cash from financing | -9.06M | 68.13% |
Net change in cash | 8.84M | 34.22% |
Free cash flow | 2.07M | — |
About
Founded
1998
Headquarters
Website
Employees
632
